QA: Karuna Therapeutics Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001771917_2023_Karuna_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001771917, Karuna Therapeutics Inc

  xvar xval
0 AssetsCurrent 1,154,769,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,201,000
3 remainder_Assets 5,364,000
4 LiabilitiesCurrent 33,946,000
5 LiabilitiesNoncurrent 3,150,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 148,029,572
9 ResearchAndDevelopmentExpense 703,769,534
10 remainder_Expenses 17,558
11 remainder_Revenues 23,595,294
12 remainder_NetIncome 62,548
13 remainder_ComprehensiveNetIncome -14,072,235
  yvar yval
0 Assets 1,163,334,000
1 Liabilities 37,096,000
2 Expenses 851,816,664
3 Revenues 23,595,294
4 StockholdersEquity 1,126,238,000
5 NetIncome -828,158,822
6 ComprehensiveNetIncome -835,194,940
7 BaseVar 1,044,988,370
8 EconomicCapitalRatiobeforeLimitedLiability 2.70
9 EconomicCapitalRatio 3.49

Edgar->Model Mapping

Feature Distribution

Change over Time